Global Health Ventures Inc. (GHLV.OB) Inks Letter of Intent with Pacific Therapeutics for Development of Pulmonary Treatment
Global Health Ventures Inc. is a specialty pharmaceutical company focused on life style products, including products for stress relief, sleeping disorders, pain relief, allergies and more. The company today announced it has signed a binding letter of intent (LOI) with Pacific Therapeutics Ltd., a development-stage specialty pharmaceutical company focused on pulmonary diseases including asthma, idiopathic pulmonary fibrosis and acute respiratory distress syndrome (ARDS). Per the agreement, Global Health will pay Pacific an upfront fee, as well as milestone payments for key clinical and regulatory achievements, and royalties on potential future sales. The two companies will equally split responsibility for all…